Skip to main content
Premium Trial:

Request an Annual Quote

NYGC: Thomas Lehner

Thomas Lehner has been appointed as scientific director of neuropsychiatric disease genomics at the New York Genome Center. He will join the center on Jan. 6, 2020. Lehner comes to the NYGC from the National Institute of Mental Health, where he was most recently director of the Office of Genomics Research Coordination and senior genomics advisor of the intramural research program. Prior to joining NIMH in 2004, he held academic research positions at Columbia University and at Rockefeller University. He also worked at Millennium Pharmaceuticals and for the New York State government. Lehner holds a PhD in human biology and genetics from the University of Vienna and a master's degree of public health from Columbia University.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.